Study of an experimental capsule for central nerve pain
Part of Brain & nervous system, Pain clinical trials.
This trial tests an investigational capsule (HSK16149) for people with moderate-to-severe central neuropathic pain—nerve pain caused by damage to the spinal cord or brain. If you qualify, you may receive the study drug or a placebo to see if it safely reduces pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can read and fill out questionnaires.
- You have had nerve pain for at least 3 months, such as pain after a stroke, from spinal cord injury, Parkinson's disease, or multiple sclerosis.
- Your average pain in the last 24 hours is at least 40 on a 0–100 scale (where 100 is the worst pain).
- You are not pregnant, not planning to become pregnant, and are willing to use reliable birth control if you could become pregnant.
- You do not have other painful conditions, unstable spinal cord injury or stroke needing surgery, or serious lab test abnormalities.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what “response profiles” different people have after treatment with high-concentration capsaicin for nerve-related pain. It may help doctors predict who benefits from capsaicin by measuring changes in symptoms and nerve sensitivity.
This trial tests an experimental pill for people with spinal cord injury who have long-term nerve pain. It aims to see if the drug can reduce pain and be safe.
This trial tests a capsule (DLBS1033) to see if it can relieve pain and improve nerve function in people with diabetic polyneuropathy. It may help reduce the numbness or tingling caused by long-term diabetes.
This study tests an investigational medicine (HL-1186) to see if it can reduce nerve pain caused by diabetes. If you have had burning or shooting pain in your feet or legs for at least 6 months, this trial might help find a new way to ease that pain.
This trial tests a new medicine called HRS-2129 for people with long-term nerve pain caused by diabetes. It aims to see if the drug can safely reduce pain.
This trial studies whether changing the “stimulation pattern” of spinal cord stimulation can reduce long-lasting pain and improve daily function. You might be a good candidate if you have chronic trunk or leg pain and have already tried multiple pain treatments without enough relief.
Hear when a new Central Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.